1999: Robert H. Cichewicz, “Dimerization of Resveratrol by the Grapevine Pathogen Botrytis cinerea,” University of Louisiana at Monroe, Monroe, LA. Advisor: Dr. Samir A. Kouzi.
2000: Valeria N. Rubin, “Preparation and Selective Estrogen-Like Bone Protective and Cholesterol-Lowering Effect of Hydroxytriarylethylenes Bearing Acidic Side Chains,” University of Georgia. Advisor: Dr. Peter C. Ruenitz
2001: Theresa L. Johnson, “Inhibition of Lactate Dehydrogenase C: The Design Synthesis, and Testing of Ligands as an Approach to Male Contraception,” University of Mississippi, Advisor: Dr. Mitchell A. Avery
2002: Kris Virga, “Structure-Based Design and Synthesis of Pantothenate Kinase Inhibitors,” University of Tennessee, Advisor, Dr. Richard E. Lee
2003: Lindsay Odom, “Alkylation and Cyclization Reactions of Diazoketones: Synthesis of Substituted Azetidines,” University of Mississippi, Advisor, Dr. John M. Rimoldi
2004: Kerim Babaolu, “Crystal Structure of Dihydropteroate Synthase from Bacillus anthracis: Studies into Mechanism and Starting Point for Novel Inhibitor Design,” University of Tennessee Health Science Center, Advisor, Dr. Richard E. Lee.
2005: Nakul Telang, “Design, Synthesis and Biological Evaluation of Isoflavones as AntigiardialAgents,” University of Mississippi, Advisor, Dr. Mitchell Avery.
2006: Tarek Mahfouz, “Computer-aided Inhibitor Discovery of the Botulinum Neurotoxin Serotype A,” University of Houston, Advisor, Dr. James M. Briggs.
2007: Kirk Hevener, “Structure-Guided Virtual Screening Against Dihydropteroate Synthase Utilizing Pharmacophore Filtering and Fragment-based Constraints,” University of Tennessee Health Science Center, Advisor, Dr. Richard E. Lee.
2008: Yatan Shukla, “Novel Pregnane Glycosides from Hoodia gordonii,” University of Mississippi, Advisor, Dr. Ikhlas A. Khan.
2009: Amir E. Wahba, “Zinc Mediated Reductive N-Alkylation and Amidation of Nitro Arenes with an Application to natural Products,” University of Mississippi, Advisor, Dr. Mark T. Hamann.
2010: Sarah Chijkowski, “The Reaction of the Sesquiterpene Lactone Repin with Various Amine Nucleophiles,” Advisor, John M. Rimoldi.
2011: Amanda Waters, “Methodologies for the Structural Assignment of Karlotoxin Polyketides in High-Throughput using Overlaid 2D NMR Techniques,” Advisor, Mark T. Hamann.
2012: Fathy Behery, “Tocotrienol Elecrophilic Substitution Products as Breast Cancer Proliferation and Migratio Inhibitory Leads,” Advisor, Khalid El Sayed.
2013: Min Xiao, “Discovery of 4-Aryl-2-benzoyl-imidazoles as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties,” Advisor, Wei Li.
2014: Eric Bow, “Novel Benzofuran and Benzopyran Scaffolds Targeting the
Cannabinoid Receptors,” Advisor, John M. Rimoldi.
2015: Chalada Suebsuwong, “Structure-Based Design of Potent and Selective DLG-OUT RIPK1 Inhibitors,” Advisor, Greg Cuny.
2016: Wang Qinghui, “Structural Optimization of ABI-231 Targeting the Colchicine Site in Tubulin for Advanced Melanoma,” Advisor, Wei Li.
2003: Srinivasan P. Venkatachalan, “Effect of Urethane on the 5HT3A and 5HT3AB Receptor,” University of Lousiana, Monroe, Advisor Dr. Marvin K Schulte.
2005: Wayun Sheng, “3D High-resolution NMR Characterizatin of Recombiant CB2 Membrane Protein Fragment,” University of Houston, Advisor, Dr. Xiang-Qun (Sean) Xie.
2006: Lukasz Kutrzeba, “In-vitro Studies on Metabolism of Salvinorin A,” University of Mississippi, Advisor,Dr. Jordan K. Zjawiony.
2007: Prasanna Sivaprakasam, “Computational Insights into PfDHFR-TS: Application of 2D,3D-QSAR and Docking Studies to Cycloguanil Derivatives,” University of Mississippi, Advisor, Dr. Robert J Doerksen.
2008: Sanju Narayanan, “Discovery of Highly Selective s2 Antagonist as Anti-cocaine Agent,” Advisor, Dr. Christopher R. McCurdy.
2009: Lacey D. Gamblin, “Synthesis of Thiourea Analogues as Potential Somatostatin Receptor Subtype 4 Agonists” Southern Illinois University, Edwardsville, Advisor, Dr. A. Michael Crider.
2010: Swapnil Kulkarni, “Studies Towards Total Synthesis of Pseudolaric Acid B,” University of Mississippi, Advisor, Mitchel A. Avery.
2011: Horrick Sharma, “Synthesis, Docking and Biological Studies of Phenanthrene b-Diketo Acids as Novel HIV-1 Integrase Inhibitors,” Advisor, John K. Buolamwini.
2012: Amanda L. Waters, Isolation and Structure Determination of Antifungal Lactone Lipids and Other Secondary Metabolites From Sooty Mold, Scorias Spongiosa,” Advisor, Mark Hamann.
2013: Chalada Suebsuwong, “An Approach to Identifying Potent and Selectifve DXG-out RIP1 Kinase Inhibitors,” Advisor, Gregory D. Cuny.
2014: Manal A. Nael, “Targeting Protein Kinase RNA-Like Endoplasmic Reticulum Kinase to Manage Alzheimer’sDisease,” Advisor, Robert J. Doerksen.
2015: Jai Shankar K. Yadlapalli, “Pharmacology, Pharmacokinetics, and Therapeutic Implications of Morphine-6-O-Sulfate sodium in Diabetic Neuropathy,” Advisor, Peter A. Crooks.
2016: Abu Bakar Siddique, “Extra-Virgin Olive Oil Based Oleocanthal: A Promising Lead for the Control of C-MET-Dependent Brest Malignancies,” Advisor, Khalid El Sayed.
2015: Pallavi Rajaputra, “Far Red Light-Activatable Prodrugs of a Photosensitizer and Anti-Cancer Drug for Effective Tumor Ablation Using Photodynamic Therapy” Advisor: Youngjae You.
2016: Staya Prakash Shukla, “Homo- and Hetero-Multimerizations of Peptoids to Target Cancer,” Advisor: Gomika Udugamasooriya.